Study of Sugemalimab (or Placebo) Plus PGemOx Regimen in Participants With Extranodal NK/T-Cell Lymphoma
Clinical trial NCT05700448 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT05700448
- Sponsor
- CStone Pharmaceuticals
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2027-06-01
- Primary completion
- 2029-12-01
- Enrollment
- 150
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.